Efficacy and Safety of Nintedanib in Patients With Advanced Idiopathic Pulmonary Fibrosis

BMC Pulmonary Medicine - United Kingdom
doi 10.1186/s12890-019-1030-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis

Internal Medicine
Internal MedicineMedicine
2013English

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients

Advances in Therapy
MedicinePharmacology
2020English

FRI0461 Efficacy and Safety of Antifibrotic Agents in Idiopathic Pulmonary Fibrosis

2018English

Recombinant Human Pentraxin-2 Therapy in Patients With Idiopathic Pulmonary Fibrosis: Safety, Pharmacokinetics and Exploratory Efficacy

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Remarkable Improvement in a Patient With Idiopathic Pulmonary Fibrosis After Treatment With Nintedanib

Internal Medicine
Internal MedicineMedicine
2019English

Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2017English

Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment

Respiratory Medicine
PulmonaryRespiratory Medicine
2019English

Psy54 - Budget Impact Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in Turkey

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy